Ahmed MH - Search Results

1

Metabolic disturbances in non-alcoholic fatty liver disease.

Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Byrne CD, et al. Among authors: ahmed mh. Clin Sci (Lond). 2009 Apr;116(7):539-64. doi: 10.1042/CS20080253. Clin Sci (Lond). 2009. PMID: 19243311 Review.

2

Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).

Ahmed MH, Byrne CD. Ahmed MH, et al. Drug Discov Today. 2007 Sep;12(17-18):740-7. doi: 10.1016/j.drudis.2007.07.009. Epub 2007 Aug 27. Drug Discov Today. 2007. PMID: 17826687 Review.

3

Current treatment of non-alcoholic fatty liver disease.

Ahmed MH, Byrne CD. Ahmed MH, et al. Diabetes Obes Metab. 2009 Mar;11(3):188-95. doi: 10.1111/j.1463-1326.2008.00926.x. Epub 2008 Jun 16. Diabetes Obes Metab. 2009. PMID: 18564173 Review.

4

Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

Ahmed MH, Abu EO, Byrne CD. Ahmed MH, et al. Prim Care Diabetes. 2010 Oct;4(3):129-37. doi: 10.1016/j.pcd.2010.02.004. Epub 2010 Mar 17. Prim Care Diabetes. 2010. PMID: 20299294 Review.

5

Bariatric surgery and renal function: a precarious balance between benefit and harm.

Ahmed MH, Byrne CD. Ahmed MH, et al. Nephrol Dial Transplant. 2010 Oct;25(10):3142-7. doi: 10.1093/ndt/gfq347. Epub 2010 Jun 21. Nephrol Dial Transplant. 2010. PMID: 20566568 Review.

6

Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?

Ahmed MH, Byrne CD. Ahmed MH, et al. Drug Discov Today. 2010 Aug;15(15-16):590-5. doi: 10.1016/j.drudis.2010.06.007. Epub 2010 Jun 18. Drug Discov Today. 2010. PMID: 20601094

7

The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.

Muhidin SO, Magan AA, Osman KA, Syed S, Ahmed MH. Muhidin SO, et al. Among authors: ahmed mh. J Obes. 2012;2012:637538. doi: 10.1155/2012/637538. Epub 2012 Dec 10. J Obes. 2012. PMID: 23304464 Free PMC article. Review.

8

Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk.

Ahmed MH, Husain NE, Malik A, Woodward C, Mital D. Ahmed MH, et al. AIDS Rev. 2017 Oct-Dec;19(4):190-197. AIDS Rev. 2017. PMID: 29271970 Review.

9

Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic.

Ahmed MH, Osman MM. Ahmed MH, et al. Br J Hosp Med (Lond). 2006 May;67(5):267. Br J Hosp Med (Lond). 2006. PMID: 16729640 No abstract available.

10

Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?

Osman KA, Osman MM, Ahmed MH. Osman KA, et al. Among authors: ahmed mh. Expert Opin Drug Saf. 2007 Jan;6(1):1-4. doi: 10.1517/14740338.6.1.1. Expert Opin Drug Saf. 2007. PMID: 17181445 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters